ICON PLC Stock Euronext Dublin
Stocks
ICLR
IE0005711209
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 147.55 EUR | +635.91% |
|
-8.66% | - |
| Market Cap | 12.85B 11.27B 10.44B 9.6B 18.16B 1,230B 18.52B 124B 48.79B 604B 48.24B 47.19B 2,085B | P/E 2026 * |
23.7x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 15.23B 13.36B 12.37B 11.39B 21.54B 1,458B 21.96B 147B 57.85B 716B 57.2B 55.95B 2,473B | EV / Sales 2026 * |
1.89x | EV / Sales 2027 * | 1.75x |
| Free-Float |
99.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ICON PLC
| 1 day | -0.50% |
| Manager | Title | Age | Since |
|---|---|---|---|
Barry Balfe
CEO | Chief Executive Officer | 48 | 01/10/2025 |
Nigel Clerkin
DFI | Director of Finance/CFO | 53 | 01/10/2024 |
Ute Berger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
John Climax
CHM | Chairman | 73 | 01/11/2002 |
Ciaran Murray
CHM | Chairman | 63 | 01/03/2017 |
Eugene McCague
BRD | Director/Board Member | 67 | 04/10/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +635.91% | -8.66% | - | - | 12.85B | |
| +0.44% | +1.41% | +4.25% | +10.81% | 50.73B | |
| -2.91% | -4.22% | +374.28% | +585.94% | 39.73B | |
| +1.81% | +2.68% | +32.07% | -3.71% | 34.69B | |
| +1.74% | -1.75% | +20.58% | +53.42% | 33.21B | |
| -0.06% | -4.63% | +2.94% | +31.65% | 26.76B | |
| -2.86% | -1.84% | - | - | 16.8B | |
| -0.51% | -5.49% | +66.72% | +122.15% | 15.37B | |
| +0.78% | +1.16% | +15.53% | +17.32% | 13.78B | |
| -2.28% | -6.83% | +1,547.46% | +646.89% | 12.11B | |
| Average | -0.47% | -1.63% | +257.98% | +183.06% | 27.02B | |
| Weighted average by Cap. | -0.26% | -0.66% | +163.19% | +160.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.06B 7.07B 6.55B 6.02B 11.39B 771B 11.61B 78.02B 30.6B 379B 30.26B 29.6B 1,308B | 8.31B 7.29B 6.75B 6.21B 11.75B 795B 11.97B 80.44B 31.55B 391B 31.2B 30.52B 1,349B |
| Net income | 520M 456M 422M 389M 735M 49.76B 749M 5.03B 1.97B 24.44B 1.95B 1.91B 84.39B | 608M 534M 494M 455M 860M 58.22B 877M 5.89B 2.31B 28.59B 2.28B 2.23B 98.74B |
| Net Debt | 2.39B 2.09B 1.94B 1.78B 3.37B 228B 3.44B 23.1B 9.06B 112B 8.96B 8.76B 387B | 1.66B 1.46B 1.35B 1.24B 2.35B 159B 2.39B 16.07B 6.3B 78.01B 6.23B 6.1B 269B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ICLR Stock
- ICLR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
